posted on 2023-04-04, 01:46authored byAlvaro G. Alvarado, Kaleab Tessema, Sree Deepthi Muthukrishnan, Mackenzie Sober, Riki Kawaguchi, Dan R. Laks, Aparna Bhaduri, Vivek Swarup, David A. Nathanson, Daniel H. Geschwind, Steven A. Goldman, Harley I. Kornblum
Gene signatures associate differentially to cell cycle, cellular states, and cell identities
Funding
UC President's Postdoctoral Fellowship
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF)
HHS | NIH | National Cancer Institute (NCI)
History
ARTICLE ABSTRACT
Molecular classification of GBM has not yet resulted in the development of effective therapies. We have developed an integrative approach to identify molecular targets differentially utilized by individual tumors. This approach could lead to patient- and tumor-specific therapeutics.